有关老年人肌少-骨质疏松症的研究进展
Journal: Basic Medical Theory Research DOI: 10.12238/bmtr.v4i5.5644
Abstract
肌少症与骨质疏松是老年人常见的退化性疾病,两者之间相互影响。它们使老年人跌倒、骨折、住院、死亡的风险增高。研究肌少-骨质疏松症,对于提高老年人的生活质量有重要意义。基于此,本文就有关老年人的肌少-骨质疏松症的诊断与评估、发病机制、治疗及干预措施进行简要综述。
Keywords
肌少症；骨质疏松；评估；发病机制；治疗
Full Text
PDF - Viewed/Downloaded: 0 TimesReferences
[1] Masanes F , Culla A,et al . Prevalence of sarcopenia in healthy community-dwelling elderly in an urban area of Barcelona (Spain). J Nutr Health Aging 2012; 16:184–7.
[2] Fielding RA, Vellas B, Evans WJ, et al. Sarcopenia: an undiagnosed condition in older adults. Current consensus definition:prevalence, etiology, and consequences. Internatio nal Working Group on sarcopenia[J]. J Am Med Dir Assoc, 2011, 12(4):249-256.
[3] 中华医学会骨质疏松和骨矿盐疾病分会.肌少症共识[J].中华骨质疏松和骨矿盐疾病杂志,2016,9(3):215-227.
[4] 中华医学会骨质疏松和骨矿盐疾病分会.原发性骨质疏松症诊疗指南(2017)[J].中华骨质疏松和骨矿盐疾病杂志,2017,10(5):413-443.
[5] Kanis JA, Melton LJ 3rd,et al.The diagnosis of osteoporosis. J Bone Miner Res Off J Am S o c B o n e M i n e r R e s 9(8):1137-1141.
[6] H.He,Y.Liu1.Relationship of sarcopenia and body compo sition with osteoporosis[J].Osteoporos Int,2015.
[7] Verschueren S, Gielen E, et al. Sarcopenia and its relationship with bone mineral density in middle-aged and elderly European men. Osteoporos Int. 2013 Jan;24(1):87-98.
[8] Cruz-Jentoft, Alfonso J et al. “Sarcopenia: revised European consensus on definition and diagnosis.” Age and ageing vol. 48,1 (2019):16-31.
[9] Han, Peipei et al.“Prevalence and Factors Associated With Sarcopenia in Suburb-dwelling Older Chinese Using the Asian Working Group for Sarcopenia Definition.” The journals of gerontology. Series A, Biological sciences and medical sciences vol.71,4(2016):529-35.
[10] E Treviño-Aguirre, T López-Teros, L Gutiérrez-Ro bledo, et al. Availability and use of dual energy X-ray absor ptiometry (DXA) and bio-impedance analysis (BIA) for the evaluation of sarcopenia by Belgian and Latin Americangeriatricians[J].Journal of Cachexia Sarcopenia & Muscle, 2014,5(1).
[11] Sarcopenia in Asia: Consensus Report of the Asian Working Group for Sarcopenia.Journal of the American Medical DirectorsAssociation15.2(2014):95-101.
[12] 陈锦成,朱国涛,刘洪文,等.“肌少-骨质疏松症”的共同发病机制[J].中华骨质疏松和骨矿盐疾病杂志,2020,13(1):95-102.
[13] Hsien-Chun Chiu,et al. Preventing muscle wasting by osteoporosis drug alendronate in vitro and in myopathy models via sirtuin-3 down-regulation.Journal of Cachexia, Sarcopenia and Muscle(2018).
[2] Fielding RA, Vellas B, Evans WJ, et al. Sarcopenia: an undiagnosed condition in older adults. Current consensus definition:prevalence, etiology, and consequences. Internatio nal Working Group on sarcopenia[J]. J Am Med Dir Assoc, 2011, 12(4):249-256.
[3] 中华医学会骨质疏松和骨矿盐疾病分会.肌少症共识[J].中华骨质疏松和骨矿盐疾病杂志,2016,9(3):215-227.
[4] 中华医学会骨质疏松和骨矿盐疾病分会.原发性骨质疏松症诊疗指南(2017)[J].中华骨质疏松和骨矿盐疾病杂志,2017,10(5):413-443.
[5] Kanis JA, Melton LJ 3rd,et al.The diagnosis of osteoporosis. J Bone Miner Res Off J Am S o c B o n e M i n e r R e s 9(8):1137-1141.
[6] H.He,Y.Liu1.Relationship of sarcopenia and body compo sition with osteoporosis[J].Osteoporos Int,2015.
[7] Verschueren S, Gielen E, et al. Sarcopenia and its relationship with bone mineral density in middle-aged and elderly European men. Osteoporos Int. 2013 Jan;24(1):87-98.
[8] Cruz-Jentoft, Alfonso J et al. “Sarcopenia: revised European consensus on definition and diagnosis.” Age and ageing vol. 48,1 (2019):16-31.
[9] Han, Peipei et al.“Prevalence and Factors Associated With Sarcopenia in Suburb-dwelling Older Chinese Using the Asian Working Group for Sarcopenia Definition.” The journals of gerontology. Series A, Biological sciences and medical sciences vol.71,4(2016):529-35.
[10] E Treviño-Aguirre, T López-Teros, L Gutiérrez-Ro bledo, et al. Availability and use of dual energy X-ray absor ptiometry (DXA) and bio-impedance analysis (BIA) for the evaluation of sarcopenia by Belgian and Latin Americangeriatricians[J].Journal of Cachexia Sarcopenia & Muscle, 2014,5(1).
[11] Sarcopenia in Asia: Consensus Report of the Asian Working Group for Sarcopenia.Journal of the American Medical DirectorsAssociation15.2(2014):95-101.
[12] 陈锦成,朱国涛,刘洪文,等.“肌少-骨质疏松症”的共同发病机制[J].中华骨质疏松和骨矿盐疾病杂志,2020,13(1):95-102.
[13] Hsien-Chun Chiu,et al. Preventing muscle wasting by osteoporosis drug alendronate in vitro and in myopathy models via sirtuin-3 down-regulation.Journal of Cachexia, Sarcopenia and Muscle(2018).
Copyright © 2022 苗晓晓, 李丹, 黄炜
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License